Global Branched Stent Grafts Market to reach USD 443 million by 2027.
Global Branched Stent Grafts Market is valued at approximately USD 260.3 million in 2020 and is anticipated to grow with a healthy growth rate of more than 7.9 % over the forecast period 2021-2027. Branched Stent Grafts are small metal scaffolds or tubes, that have strengthened openings or branches that enable the physician to attach arteries that are leading to other organs. the graft is taken to the spot of the aneurysm through a catheter, implanted via skin in the groin area and threaded a blood vessel. These are made commercial after 2012 for the required applications. Increased adoption of endovascular aneurysm repair procedures is expected to fuel the Branched Stent Grafts Market. Global rise in geriatric population is also propelling the market growth. For instance, according to the U.S. Census Bureau, an estimates 75 million of the 328 million U.S. population were aged 60 years and older in 2019, implying a significant number of American citizens are prone to chronic and acute conditions, increased number of surgeries.

However, high cost of device and diagnosis may impede market growth over the forecast period of 2021-2027.

The regional analysis of the global Branched Stent Grafts Market considers the key regions such as Asia Pacific, North America, Europe, Latin America, and Rest of the World (ROW). Asia-pacific is expected to dominate the market in the forecast period. The driving factors are expected to be increasing investments on healthcare and growing medical tourism in the region. It covers the growing economies such as China, Japan, India and Australia, ensuring the presence of better health infrastructure , affordability and convenience, are expected to fuel the growth or Branched Stent Grafts market in the region. However, North America is expected to follow Asia-Pacific by holding the largest revenue share of more than 49% in 2021. This can be credited to the presence of well-developed healthcare infrastructure, reimbursement coverage and key players in the region. Along with this, major market players presence makes the regional market more competitive.


Major market player included in this report are:

Medtronic
Biotronik
Alvimedica
Endocor GmbH
Eucatech AG
Merit Medical Systems
Abbott
Cook Medical
Cardinal Health (Cordis)
Boston Scientific Corp.
Terumo Corp

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:
Iliac Stent
Others
By Application:
EVAR Endovascular Aneurysm Repair)
FEVAR (Fenestrated Endografts)

Chimney
Others

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2017, 2018-19
Base year - 2019-2020
Forecast period - 2021 to 2027.

Target Audience of the Global BRANCHED STENT GRAFTS MARKET Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors